Natco receives tentative FDA approval for generic Tamiflu

HYDERABAD — Natco Pharma received tentative approval from the Food and Drug Administration to launch a generic version of Roche Holding AG's Tamiflu, according to a recent report. The drug is used to treat bird and swine flu.

The company has tentative approval to launch the drug (oseltamivir phosphate) in capsules of 30-mg, 45-mg and 75-mg dosage. Natco will partner with Alvogen to market the drug in the United States.